Access and Rules for GLP-1 Medicines
Guidelines on how to access GLP-1 medicines in the UK, including NHS and private routes.
Accessing GLP-1 Medicines on the NHS
In the UK, GLP-1 medicines are available through the NHS, but access is subject to specific eligibility criteria. A clinician will assess whether a patient meets these criteria based on their health needs.
Private Access to GLP-1 Medicines
Many individuals choose to access GLP-1 medicines through regulated private services. It's essential to ensure that these services conduct proper consultations and assessments to ensure safety.
Understanding the Role of MHRA and NICE
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for licensing medicines, while the National Institute for Health and Care Excellence (NICE) determines which treatments the NHS should fund. Understanding their roles can clarify the access process.